ivWatch Finds Strong Ally in Philips to Monitor Peripheral IVs
When it comes to peripheral intravenous (IV) therapy, doctors and nurses have come to accept that things might not go smoothly. Nearly 80% of hospital patients in the U.S. receive an IV — a procedure that has a startling 50% fail rate. ivWatch, the only provider of continuous non-invasive monitoring devices that can detect IV infiltrations and extravasations, hopes to curb those numbers after announcing that their devices will now be compatible with Philips Intellivue Patient Monitors. “For too long IV infiltration has been an accepted outcome of peripheral intravenous therapy,” says Gary Warren, preside...
Source: MDDI - July 5, 2018 Category: Medical Devices Authors: Kristopher Sturgis Tags: IV Products Source Type: news
How I convince the needle-wary to try IV therapy
RecoverMD in Timonium offers IV therapy to the hungover as well as those just feeling sick and dehydrated. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 11, 2018 Category: American Health Authors: Morgan Eichensehr Source Type: news
What Causes Hyponatremia?
Discussion Normal kidneys regulate water balance to maintain a plasma osmolality of 275-290 mOsm/kg normally. Thirst and arginine vasopressin or antidiuretic hormone (ADH) are the primary regulators of plasma osmolality. ADH is made in the hypothalamus and released by the posterior pituitary gland. ADH acts on the kidney’s distal collecting duct to increase water reabsorption. ADH is appropriately released in hypovolemic states, such as dehydration caused by gastroenteritis. ADH has an ~10 minute half-life and therefore can respond to rapid changes in volume status. Sodium balance is regulated by aldosterone (as part...
Source: PediatricEducation.org - April 23, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
I ’m an Engineer, But I Can’t Fix Stupid
“You can’t fix stupid,” a phrase I’ve heard engineers use about consumers, can and should be applied to medical device companies that refuse to adapt to customer needs. Consumers lead enterprise, and healthcare must start thinking like the consumer-oriented market we are becoming and develop products that are stupid simple to use. Some of us are regular consumers of the healthcare system, but more often than not, most people, especially younger generations, have infrequent interactions with the healthcare system because they don’t have to make significant decisions related to their well-being....
Source: MDDI - March 29, 2018 Category: Medical Devices Authors: Gary Warren Tags: Design Source Type: news
Make the Diagnosis: Itchy Fingers from IV Therapy?
(MedPage Today) -- Case Findings: A 48-year-old woman who was receiving IV immunoglobulin therapy complained to her doctor that over the past few weeks small vesicles had formed along the sides of her fingers. Some had ruptured and become scaly papules. Her fingers were extremely pruritic, and she said it was " driving her crazy. " Can you diagnose the patient? (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 20, 2018 Category: Dermatology Source Type: news
Vitamin deficiency we are all born with
I’ve admired Linus Pauling for years. In 1976, the Nobel Prize-winning chemist gave mega doses of vitamin C to 100 “untreatable” cancer patients. He then compared these so-called terminal patients to patients with the same kind of cancer who didn’t get vitamin C. The patients who received the traditional cancer treatment lived for an average of six months. Pauling’s patients lived — on average — for six years. You’d think that the medical community would have heralded Pauling’s research as a huge breakthrough in cancer treatment. But they didn’t. And they still ...
Source: Al Sears, MD Natural Remedies - January 17, 2018 Category: Complementary Medicine Authors: Cathy Card Tags: Health Natural Cures Nutrition anti-cancer leukemia vitamin vitamin C Source Type: news
ClearLine MD(TM) Secures $5.5MM Funding for Commercialization of ClearLine IV(TM)
WOBURN, Mass., Jan. 9, 2018 -- (Healthcare Sales & Marketing Network) -- ClearLine MD, a medical device company focused on reducing the impact of iatrogenic Air Burden to patients and improving the safety and effectiveness of intravenous (IV) therapy, tod... Devices, Venture Capital ClearLine MD, ClearLine, iatrogenic Air, intravenous (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 9, 2018 Category: Pharmaceuticals Source Type: news
BESPONSA (inotuzumab ozogamicin) Approved for Treatment of Adult Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia, available for order at Biologics, Inc.
CARY, N.C. (August 22, 2017) —Biologics, Inc., a McKesson Specialty Health oncology pharmacy services company, announced today it has been selected by Pfizer, Inc. to be a specialty pharmacy provider for BESPONSA® (inotuzumab ozogamicin), a promising new IV therapy for adult patients with relapsed o... (Source: McKesson News)
Source: McKesson News - August 22, 2017 Category: Information Technology Source Type: news
Staff Nurse at University Hospitals Birmingham NHS Foundation Trust
Employer: University Hospitals Birmingham NHS Foundation TrustDepartment: EndocrinologyLocation: BirminghamSalary:£22,128 -£28,746Job Reference: 304-A-17-37809University Hospitals Birmingham are currently looking to recruit a dynamic, enthusiastic, motivated and forward thinking registered nurse to join the Endocrine Clinical Nurse Specialist Team. This excellent opportunity is open to Band 5 nurses with at least 2 years of experience in acute care setting. Successful candidate will join a team of experienced specialist nurses in a tertiary Endocrine referral centre and will be given f...
Source: Society for Endocrinology - July 14, 2017 Category: Endocrinology Source Type: news
No Late Clinical Gain With Early IV Therapy: TRUE-AHF Published No Late Clinical Gain With Early IV Therapy: TRUE-AHF Published
Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 14, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news
Clinical Nurse Specialist in Endocrinology - University Hospitals Birmingham NHS Foundation Trust
Job reference: 304-A-17-32566Salary:£26,302 -£35,225This excellent opportunity is open to experienced registered nurses with at least 5 years’ experience in acute care setting. Candidates with experience in endocrinology are highly encouraged to consider this post.The successful candidate will join a team of experienced specialist nurses in a tertiary Endocrine referral centre and will be given full structured training and supervision to develop his/her skills in Endocrinology.The department has close links with the University of Birmingham, Birmingham Children’s Hospital and Birming...
Source: Society for Endocrinology - March 23, 2017 Category: Endocrinology Source Type: news
Minimally-invasive migraine treatment for adults works on kids, too
[Image from Tagosaku on Flickr]Migraine treatment that has been safe for adults has recently proven to be safe for use in children as well. The minimally-invasive treatment only takes a few minutes for children and teenagers to be able to feel the effects. The treatment involves a sphenopalatine ganglion (SPG) block that does not need needles. It uses a small, flexible catheter that is put into each nostril that delivers a local anesthetic to the SPG, which has often been considered the nerve bundle that causes migraines, that is in the back of the nose. The treatment disables the SPG and resets the headache circuit, reduc...
Source: Mass Device - March 13, 2017 Category: Medical Equipment Authors: Danielle Kirsh Tags: Pain Management MedTech migraines Phoenix Children's Hospital radiology Source Type: news
Don't Repeal Me, Please!
I am luckier than most. After 20 years of having multiple sclerosis I am still relatively healthy. I have a spot on my foot which is mildly numb most of the time and markedly numb when I have an exacerbation. This is damage I got from not treating an exacerbation with steroid therapy. Sometimes when I am dancing I can feel weakness in my legs, but I still dance. I will always dance. Heat and I have a love/hate relationship. I love a sauna in January. That first sweat is such a cleansing feeling. But a prolonged heat wave in summer will sap me like an iPhone battery. I have extreme vertigo whenever I ride a canoe, an amusem...
Source: Healthy Living - The Huffington Post - January 16, 2017 Category: Consumer Health News Source Type: news
Dr. A Lopez and Associates Now Offering Inexpensive Stem Cell Therapy...
Dr. A Lopez and Associates are now offering inexpensive stem cell treatments in Southern Arizona and Sonora Mexico. The treatments involve therapy for bone and joint conditions along with IV therapy...(PRWeb November 10, 2016)Read the full story at http://www.prweb.com/releases/stem-cell-therapy/arizona-sonora-mx/prweb13832734.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 10, 2016 Category: Pharmaceuticals Source Type: news
Trilogy Tactical Medicine offering TECC Nationwide
Trilogy's Tactical Medicine Division has launched a nationwide TECC training program for Fire and EMS agencies. Building on the success of Trilogy's Law Enforcement Street Survival & Tactical Medicine Instructor program, providing the NAEMT TECC course to coincide with the law enforcement training is the next logical progression. It is Trilogy's mission to reach as many street personnel as possible to provide this critical training. It reinforces the Hartford Consensus and prepares EMS personnel to work efficiently and safely in an active shooter or similar situation. Training with tourniquets and hemostatic agents ...
Source: JEMS: Journal of Emergency Medical Services News - October 31, 2016 Category: Emergency Medicine Tags: Training Industry News Source Type: news
Glutathione Benefits: Boosting Levels For Long, Healthy Life
Many people who live to be 100 or more have something in common. And it’s not that they’ve followed conventional “wisdom” about healthy diet and exercise. It’s that their bodies make more of a powerful antioxidant called glutathione than the average person. It’s what keeps them from being ravaged by the toxic world we live in. Glutathione is an important antioxidant produced by the body By now you know your body is under attack every day from the air you breathe, the chemicals you use, and the processed foods you eat. These toxins cause your body to produce free radicals. Here’s w...
Source: Al Sears, MD Natural Remedies - September 2, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Health Source Type: news
Chelation Remains A Hopeful Heart Therapy
Maybe you know someone who has suffered a heart attack. You're concerned about their well-being, particularly if they're diabetic or suffered a large heart attack. You want to make sure that absolutely everything that can help this loved one stay healthy and alive is discussed with their doctors. Odds are very high, however, that there's one promising therapy the doctor won't tell them about: chelation therapy. Chelation therapy was designed decades ago to trap and remove serious environmental toxins like arsenic. While using it, some practitioners noted improvements in symptoms of heart disease, and chelation began to ...
Source: Healthy Living - The Huffington Post - July 1, 2016 Category: Consumer Health News Source Type: news
IV vitamin therapy: increasingly trendy but 'no evidence' it works
IV therapy — delivering vitamins, minerals, amino acids and saline intravenously — is often sold as a way to boost energy and revitalize its recipients. Use of the therapy is accelerating, expert say, thanks in large part to celebrity endorsements — but there's no reason to think it works. (Source: CBC | Health)
Source: CBC | Health - June 27, 2016 Category: Consumer Health News Tags: News/Health Source Type: news
Fresenius, Smiths in the hunt for Pfizer’s $1.5B infusion pump biz
Germany’s Fresenius (NYSE:FMS) and Britain’s Smiths Group (LON:SMIN) have emerged as the final bidders for Pfizer‘s (NYSE:PFE) infusion pump business, inherited via the Big Pharma’s September 2015 purchase of Hospira for $15 billion. The winning bid is expected to be around $1.5 billion, according to Reuters. Private equity firm Pamplona Capital Management was also interested and reportedly made a 2nd-round bid in April, when the estimated price tag for unit was $2 billion, according to Bloomberg. During the 1st 3 quarters of 2014, Hospira’s medication management ...
Source: Mass Device - June 7, 2016 Category: Medical Equipment Authors: Varun Saxena Tags: Drug Pumps Mergers & Acquisitions Wall Street Beat Fresenius Medical Care Hospira Inc. Pfizer Inc. Smiths Group plc Source Type: news
IV Therapy “Cocktail” For a Cancer Patient
Today, I want to talk to you about my patient D.B. A key treatment I offer at the Sears Institute for Anti-Aging Medicine turned her life around and boosted her chances of recovering from cancer. D.B had been a vivacious 47-year-old woman, who’d always led a healthy life. For years, she’d watched her diet carefully and exercised regularly. But then she was diagnosed with endometrial cancer. This is cancer of the inner lining of the uterus. When she came to my clinic, she’d already undergone a hysterectomy and chemotherapy. Unsurprisingly, she felt terrible. She was pale. She felt lethargic and she was ex...
Source: Al Sears, MD Natural Remedies - February 19, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Women's Health Cancer IV Therapy myers cocktail nutrients vitamins Source Type: news
Regulating IV infusion with innovative blind cave fish-inspired sensor
Nurses’ workload reduced with the use of this low-cost sensor, while increasing their productivity by 30%; also significantly decreasing the complications of drug infusion via IV therapy. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 21, 2016 Category: Science Source Type: news
Insider’s guide to care: Doctors and dogs
Olivia and Dayton Olivia Burgess knows every nook and cranny of Boston Children’s Hospital. The 13-year-old and her parents have traveled from their home in Bermuda to Boston since Olivia was three years old for ongoing treatments for systemic onset juvenile rheumatoid (idiopathic) arthritis and pediatric lupus. “The unpredictable and severe nature of Olivia’s condition and the frequent travel required for medical treatment can be stressful at times,” says her mother Traci. Olivia sees providers in multiple departments: cardiology, nephrology, pulmonology, dermatology, neurology, gastroenterology an...
Source: Thrive, Children's Hospital Boston - January 4, 2016 Category: Pediatrics Authors: Lisa Fratt Tags: Our Patients’ Stories Fatma Dedeoglu juvenile rheumatoid arthritis Marybeth Son Pawprints Program pediatric lupus rheumatology program Robert Geggel Sitaram Emani Source Type: news
Boutique Hangover Clinics Are All The Rage, But Doctors Say The Best Remedies Are Free
The Hangover Clinic, a new center in Australia, joins a growing number of facilities that heal the ailments of over drinking with IV therapies. But these treatments aren’t worth the triple digit price tag. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 16, 2015 Category: Pharmaceuticals Authors: Emily Canal Source Type: news
Parker Pain Relief Clinic Now Offering Class IV Therapy Laser
(Source: Medical News (via PRIMEZONE))
Source: Medical News (via PRIMEZONE) - December 6, 2015 Category: Pharmaceuticals Source Type: news
Edwards Lifesciences, BD’s CareFusion ink interoperability pact
Edwards Lifesciences (NYSE:EW) and Becton Dickinson (NYSE:BDX) subsidiary CareFusion said today that they inked an interoperability pact for their respective hemodynamic monitoring and IV fluid administration offerings. The focus will be on hydration for moderate- to high-risk surgical patients using Edwards’ hemodynamic monitoring systems and fluid management algorithms and CareFusion’s Alaris infusion systems, they said. The collaboration aims to examine any correlation between appropriately hydrated patients and improved outcomes, the companies said. “We are prou...
Source: Mass Device - October 23, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Cardiovascular Hospital Care Surgical Becton Dickinson & Co. CareFusion Corp. Edwards Lifesciences Source Type: news
Nurse has first use of 'unique' IV cannula in community
A “unique” midline cannula previously only available in hospitals has been used for the first time in the community by a specialist intravenous therapy nurse. (Source: Nursing Times Breaking News)
Source: Nursing Times Breaking News - October 6, 2015 Category: Nursing Source Type: news
Should Ondansetron Be Used for Acute Gastroenteritis?
Discussion Acute gastroenteritis (AGE) is a common illness worldwide and is “…defined as a decrease in the consistency of stools (loose or liquid) and/or an increase in the frequency of evacuations with or without fever or vomiting….” It is one of the most common reasons for seeking medical care and hospitalizations. In Europe, rotavirus and noroviruses are two of the most frequent viral agents causing AGE and Campylobacter and Salmonella are the most common bacterial AGE causes. For parasitic infections Giardia, and Crytosporidium are most common parasitic infections in Europe. Recommendations f...
Source: PediatricEducation.org - August 24, 2015 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
AngioDynamics launches BioFlo midline cath
AngioDynamics (NSDQ:ANGO) said today it launched the BioFlo Midline catheter, indicated for short-term intravenous therapies. Albany, N.Y.-based AngioDynamics won FDA 510(k) clearance for the BioFlo earlier this year, the company said. Midline catheters provide intravenous access for up to 30 days, longer than peripheral intravenous catheters which need to be replaced every few days, the company said. “The BioFlo Midline catheter is a logical extension of the BioFlo product line, bringing the clinically relevant thrombus reduction properties to patients needing shorter term vascular access to deliver infusion th...
Source: Mass Device - August 4, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Catheters Vascular AngioDynamics Inc. Source Type: news
A Therapy That Rebuilds Your Defenses FAST
In ancient times, our ancestors had pure sources of the nutrients they needed to thrive. But they were limited in terms of how much they could get of any particular one. Organ meat gives you a wealth of nutrients, including protein, CoQ10, and a host of vitamins. But you can’t get really high doses of a nutrient or vitamin through food alone. That wasn’t a big issue for our ancestors because they had such a well-balanced environment. But it’s a big deal for you and me. In our toxic world, large doses of nutrients are sometimes necessary to balance or “straighten out” health concerns. This is a...
Source: Al Sears, MD Natural Remedies - August 3, 2015 Category: Complementary Medicine Authors: Dr. Al Sears Tags: Anti-Aging Source Type: news
Teleflex updates on Q2 earnings, FDA clearances, acquisitions, deals & study data.
This study, when combined with the 2 earlier independent studies by the same team, shows that using an Arrow CVC with antimicrobial protection from Teleflex makes sense from many perspectives. This study is further evidence that using an unprotected catheter may put both patients and a hospital’s bottom line at unnecessary risk. The Arrow CVC with Arrow+ard Technology has been repeatedly shown to improve patient safety even when the risk of infection is low, and it more than pays for itself in the process,” vascular access division prez Jay White said in a prepared statement. The Arrow catheter a...
Source: Mass Device - July 30, 2015 Category: Medical Equipment Authors: Fink Densford Tags: 510(k) Business/Financial News Cardiovascular Catheters Food & Drug Administration (FDA) MassDevice Earnings Roundup Mergers & Acquisitions Regulatory/Compliance Surgical Teleflex Source Type: news
Guidelines Released for Exercise-Associated HyponatremiaGuidelines Released for Exercise-Associated Hyponatremia
A consensus panel says symptom severity should guide treatment, including intravenous therapy with hypertonic saline for athletes presenting with symptoms of life-threatening sodium imbalance. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 3, 2015 Category: Consumer Health News Tags: Emergency Medicine News Source Type: news
Does IV therapy really cure hangovers?
Drank too much and have work to do? Some companies like the Hangover Club claim they have the answer, for a price (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - April 18, 2015 Category: Consumer Health News Source Type: news
ivWatch Receives FDA Clearance And Significantly Advances Safety Of IV Therapy
Peripheral IV therapy is a common part of many hospital visits, but it can often result in adverse events that, until now, have been accepted as the norm. (Source: Medical Design Online News)
Source: Medical Design Online News - April 13, 2015 Category: Medical Equipment Source Type: news
Ebola Doctors Are Divided on IV Therapy in Africa
Doctors seeking to stem the Ebola epidemic disagree on whether most patients in West Africa should, or can, be given intravenous hydration, a standard therapy in developed countries. (Source: NYT Health)
Source: NYT Health - January 2, 2015 Category: Consumer Health News Authors: By DONALD G. McNEIL Jr. Tags: Epidemics Centers for Disease Control and Prevention Doctors Without Borders Ebola Virus Partners in Health Africa World Health Organization Source Type: news
Ebola Doctors Are Divided on IV Therapy in Africa
Doctors seeking to stem the Ebola epidemic disagree on whether most patients in West Africa should, or can, be given intravenous hydration, a standard therapy in developed countries. (Source: NYT)
Source: NYT - January 2, 2015 Category: American Health Authors: By DONALD G. McNEIL Jr. Tags: Epidemics Centers for Disease Control and Prevention Doctors Without Borders Ebola Virus Partners in Health Africa World Health Organization Source Type: news
Fluid Management in Diabetic KetoacidosisFluid Management in Diabetic Ketoacidosis
Why aren't patients with DKA receiving prompt IV therapy? The British Journal of Diabetes and Vascular Disease (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 10, 2013 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
Early IV Therapy in Older Patients With Acute HFEarly IV Therapy in Older Patients With Acute HF
Keep time on your side with IV therapies for acute heart failure, especially with elderly patients. American Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 4, 2013 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Drug design success propels efforts to fight HIV with a combination of 2 FDA-approved drugs
A University of Minnesota research team featuring researchers from the Institute for Molecular Virology, School of Dentistry and Center for Drug Design has developed a new delivery system for a combination of two FDA approved drugs that may serve as an effective treatment for the human immunodeficiency virus (HIV). The discovery, which allows for a combination of decitabine and gemcitabine to be delivered in pill form, marks a major step forward in patient feasibility for the drugs, which previously had been available solely via injection or intravenous therapy (IV)... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 4, 2013 Category: Consumer Health News Tags: HIV / AIDS Source Type: news
Drug design success propels efforts to fight HIV with a combination of 2 FDA-approved drugs
(University of Minnesota Academic Health Center) A University of Minnesota research team has developed a new delivery system for a combination of two FDA approved drugs that may serve as an effective treatment for the human immunodeficiency virus. The discovery, which allows for a combination of decitabine and gemcitabine to be delivered in pill form, marks a major step forward in patient feasibility for the drugs, which previously had been available solely via injection or intravenous therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 30, 2013 Category: Global & Universal Source Type: news
Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents
The Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents document was published in an electronic format that could be easily updated as relevant changes in prevention and treatment recommendations occur. The editors and subject matter experts are committed to timely changes in this document because so many health care providers, patients, and policy experts rely on this source for vital clinical information. All changes are developed by the subject matter groups listed in the document (changes in group composition are also promptly posted). These changes are revi...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - July 8, 2013 Category: Infectious Diseases Source Type: news
Tangent Medical Announces U.S. Launch Of The NovaCath™ Integrated IV Catheter System
Tangent Medical (www.tangentmedical.com), an innovator in IV therapy products and creator of the NovaCath™ Integrated IV Catheter System, announced today its commercial product launch and start to clinical evaluations in several healthcare facilities across the U.S (Source: Medical Design Online News)
Source: Medical Design Online News - July 1, 2013 Category: Medical Equipment Source Type: news
BiV Pacing vs RV Pacing in AV BlockBiV Pacing vs RV Pacing in AV Block
The study showed that patients randomized to biventricular pacing had a significantly lower incidence of the primary end point, a composite of all-cause mortality, hospitalization for heart failure requiring intravenous therapy, or a 15% or more increase in the left ventricular end-systolic volume index. Heartwire (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 26, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news
Biventricular bests RV pacing in patients with AV block: BLOCK HF published
The study showed that patients randomized to biventricular pacing had a significantly lower incidence of the primary end point, a composite of all-cause mortality, hospitalization for heart failure requiring intravenous therapy, or a 15% or more increase in the left ventricular end-systolic volume index. (Source: theHeart.org)
Source: theHeart.org - April 25, 2013 Category: Cardiology Source Type: news
Combination Therapy for Migraine in the Pediatric EDCombination Therapy for Migraine in the Pediatric ED
This study compared outcomes of pediatric migraine patients treated in an ED before and after implementation of a standardized combination IV therapy regimen. Headache (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 23, 2013 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news